Therapeutic Education for Harm Reduction in People With Alcohol Use Disorder
NCT ID: NCT03954054
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2019-10-28
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
ETHER ("Education THEérapeutique pour la Réduction des dommages en alcoologie" or therapeutic education for the reduction of alcohol-related harms) is an ongoing, multicentre, community-based mixed-methods study, which aims to evaluate the innovative therapeutic patient education (TPE) programme named "Choizitaconso". This programme teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.
The evaluation of the programme will rely on a sequential explanatory design, where the qualitative study (16 semi-structured interviews) will assist in explaining and interpreting the findings of the controlled before-and-after quantitative study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapist-guided Internet Treatment for Hazardous and Harmful Alcohol Use. A Feasibility Study
NCT04544930
Evaluation of an Internet-based Intervention for Hazardous Drinkers
NCT01075685
Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care
NCT02671019
Feasibility and Potential Effectiveness of a Case Management Intervention for Alcohol Use-Related Problems in Frequent Users of an Emergency Department: a Pilot Study
NCT04938258
Addiction Risk: Psychoeducational Intervention to Change Risk Perception Among Alcohol Patients in Residential Treatment
NCT03339674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
34 questions on alcohol-related harms were identified in the international literature and approved by the PWAUD community. The sum of these harms, considered as a measure of the individual "burden" related to alcohol use, will be used as principal outcome.
Secondary outcomes are quantity and frequency of alcohol consumption, craving for alcohol, coping strategies, Health-Related Quality of Life (HRQL), self-confidence to resist drinking, anticipated and internalized stigma, treatment self-regulation, anxiety and depressive symptoms, alcohol-related neuropsychological impairments and capabilities (i.e., a measure of wellbeing for the general adult population, used in economic evaluations).
Primary and secondary outcomes will be collected in face-to-face and phone-based interviews at enrolment and 6 months after enrolment. We will use a binomial test and linear regression models to assess the impact of the TPE programme on changes in the principal and secondary outcomes, while adjusting for other correlates and confounders.
The study's qualitative component comprises semi-structured interviews of 16 PWAUD who completed the TPE programme at least 6 months before the interview. Qualitative interviews will be analysed using thematic analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Former therapeutic education participants
Semi-structured interviews with people who already completed the TPE programme
"Choizitaconso" - therapeutic patient education programme
Choizitaconso is a therapeutic patient education programme that teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.
It lasts for 10 weeks for each participant and consists of the following 5 modules, including one optional module focusing on the family environment:
1. Understand the mechanisms that trigger and/or maintain alcohol-related difficulties
2. Plan and evaluate personalized controlled drinking strategies
3. Understand and identify external and internal influences (e.g., thoughts and emotions), identify and manage risk situations
4. Identify alcohol effects and alcohol-related expectations (by developing self-observation skills)
5. Family environment: learning how to evaluate and take care of oneself (e.g., how to express feelings)
Each module consists of 2 to 4 collective workshops that each last 120 minutes and involve 5 to 10 persons.
Intervention group (current therapeutic education participants)
A face-to-face interview and a telephone interview at treatment initiation (M0) and 6 months after programme initiation (M6)
Administration of socio-economic questionnaires and a Brief Evaluation of Alcohol-Related Neuropsychological Impairment (BEARNI) before, and 6 months after inclusion in the therapeutic education programme.
"Choizitaconso" - therapeutic patient education programme
Choizitaconso is a therapeutic patient education programme that teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.
It lasts for 10 weeks for each participant and consists of the following 5 modules, including one optional module focusing on the family environment:
1. Understand the mechanisms that trigger and/or maintain alcohol-related difficulties
2. Plan and evaluate personalized controlled drinking strategies
3. Understand and identify external and internal influences (e.g., thoughts and emotions), identify and manage risk situations
4. Identify alcohol effects and alcohol-related expectations (by developing self-observation skills)
5. Family environment: learning how to evaluate and take care of oneself (e.g., how to express feelings)
Each module consists of 2 to 4 collective workshops that each last 120 minutes and involve 5 to 10 persons.
Control AUD (Alcohol Use Disorder) patients
A face-to-face interview and a telephone interview at treatment initiation (M0) and 6 months after programme initiation (M6)
Administration of socio-economic questionnaires and a Brief Evaluation of Alcohol-Related Neuropsychological Impairment (BEARNI) before, and 6 months after inclusion in the therapeutic education programme.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Choizitaconso" - therapeutic patient education programme
Choizitaconso is a therapeutic patient education programme that teaches psychosocial skills to people with alcohol use disorder (PWAUD), to help them (re)establish controlled drinking and reduce harms.
It lasts for 10 weeks for each participant and consists of the following 5 modules, including one optional module focusing on the family environment:
1. Understand the mechanisms that trigger and/or maintain alcohol-related difficulties
2. Plan and evaluate personalized controlled drinking strategies
3. Understand and identify external and internal influences (e.g., thoughts and emotions), identify and manage risk situations
4. Identify alcohol effects and alcohol-related expectations (by developing self-observation skills)
5. Family environment: learning how to evaluate and take care of oneself (e.g., how to express feelings)
Each module consists of 2 to 4 collective workshops that each last 120 minutes and involve 5 to 10 persons.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fluent in French speaker
* able to provide written, informed consent
* reachable by phone
* followed-up for Alcohol Use Disorder
Exclusion Criteria
* being a legally-protected adult (tutorship, curatorship)
* being pregnant
* participation in another study during the duration of follow-up (6 months)
* having severe cognitive impairment which could conflict with successful group work
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regional Agency for Health PACA
OTHER
SESSTIM UMR1252 (Aix-Marseille Univ, INSERM, IRD)
UNKNOWN
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CSAPA Convergence
Avignon, , France
ANPAA 04
Digne-les-Bains, , France
Clinique Saint Barnabé
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barre T, Ramier C, Antwerpes S, Costa M, Bureau M, Maradan G, Di Beo V, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Dufort S, Protopopescu C, Marcellin F, Casanova D, Coste M, Carrieri P. A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study). Drug Alcohol Rev. 2023 Mar;42(3):664-679. doi: 10.1111/dar.13605. Epub 2023 Jan 31.
Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barre T, Casanova D, Carrieri P. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduct J. 2022 Jan 10;19(1):2. doi: 10.1186/s12954-021-00587-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C19-03 / ETHER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.